期刊
NEUROCHEMISTRY INTERNATIONAL
卷 140, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2020.104814
关键词
PPAR-gamma; PGC-1 alpha signaling; Endogenous ligand; Oxidative stress; Mitochondrial biogenesis; Agonists; Neuroprotection
资金
- Science and Engineering Research Board (SERB), New Delhi, India [CRG/2018/002084]
- JSS Academy of Higher Education & Research, Mysuru, India
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) is one of the ligand-activated transcription factors which regulates a number of central events and considered as a promising target for various neurodegenerative disease conditions. Numerous reports implicate that PPAR-gamma agonists have shown neuroprotective effects by regulating genes transcription associated with the pathogenesis of neurodegeneration. In regards, this review critically appraises the recent knowledge of PPAR-gamma receptors in neuroprotection in order to hypothesize potential neuroprotective mechanism of PPAR-gamma agonism in chronic neurological conditions. Of note, the PPAR-gamma's interaction dynamics with PPAR-gamma coactivator-1 alpha (PGC-1 alpha) has gained significant attention for neuroprotection. Likewise, a plethora of studies suggest that the PPAR-gamma pathway can be actuated by the endogenous ligands present in the CNS and thus identification and development of novel agonist for the PPAR-gamma receptor holds a vow to prevent neurodegeneration. Together, the critical insights of this review enlighten the translational possibilities of developing novel neuroprotective therapeutics targeting PPAR-gamma for various neurodegenerative disease conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据